Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

Background The Japanese Children’s Cancer Group (JCCG) NeuroblastomaCommittee (JNBSG) conducted a phase II clinical trial for high-risk neuroblastomatreatment. We report the result of the protocol treatment and associated genomic aberration studies.